SK

Sanjeev Kumar Sharma

Active Director Director DIN 08618596
DIN 08618596 First appointment Nov 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Sanjeev Kumar Sharma

Data last updated:

Sanjeev Kumar Sharma is a Director at Cadlay Pharma Private Limited (since 2019). The company operates in Pharma. Cadlay Pharma Private Limited reported revenue of ₹3.27 Cr (FY 2024).

DIN 08618596
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2019
Oldest Company Age 6 yrs
Largest company Cadlay Pharma Private Limited · ₹3.27 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cadlay Pharma Private Limited U74999HP2019PTC007708
Director21 Nov 20192019₹3.27 Cr (FY 2024)Active

Board colleagues of Sanjeev Kumar Sharma

Directorship timeline

Open interactive timeline →
Cadlay Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjeev Kumar Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeev Kumar Sharma

Sanjeev Kumar Sharma currently holds 1 directorship: Cadlay Pharma Private Limited (Director, since 21 Nov 2019, revenue ₹3.27 Cr (FY 2024)).

Sanjeev Kumar Sharma was first appointed on 21 Nov 2019 as Director at Cadlay Pharma Private Limited.

The current boards of Sanjeev Kumar Sharma's companies include Chitra Sharma (Cadlay Pharma Private Limited), Dilip Kumar Ghosh (Cadlay Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available